DHSC

Market Access
reviewing data

Progress with the UK’s VPAG

Leela Barham looks at the first operational review meeting minutes that have been published on the VPAG, the UK’s latest scheme on branded medicines pricing and access, building on previous

Market Access
pricing and transparency

How transparent is the VPAG?

Leela Barham takes a look at the transparency of the UK’s new pricing and access scheme, the 2024 VPAG, based on public sources.

Sales & Marketing
shapes pricing and access

How transparent is the VPAS?

The UK’s VPAS – a deal that began on 1st January 2019 and which is due to end on 31st December 2023 – is worth around £7 billion.